Pathogenic G α o Mutants Drive Dominant GPCR Coupling in GNAO1 Encephalopathies
The FASEB Journal · 2026
DOI: 10.1096/fj.202503265r ↗Kurz gefasst
Fachartikel in der Zeitschrift The FASEB Journal, 2026. Verfasst von Yonika A Larasati und 4 weiteren Autor:innen. Beteiligte Einrichtung: Translational Research Center in Oncohaematology, Department of Cell Physiology and Metabolism, Faculty of Medicine, University of Geneva, Geneva, Sw…. Hauptthemen laut MEDLINE: GTP-Binding Protein alpha Subunits, Gi-Go, Receptors, G-Protein-Coupled, Mutation, Brain Diseases. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 63 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Heterozygous mutations in GNAO1 , which encodes the G α o subunit of heterotrimeric G proteins, cause a spectrum of neurodevelopmental disorders ranging from early‐onset epileptic encephalopathy to dystonia. Although the mechanisms underlying disease dominance remain incompletely understood, some functional disruptions in G α o mutants have been described. Intriguingly, several G α o variants have been independently reported to dominantly engage G protein‐coupled receptors (GPCRs) or to sequester G β γ—two seemingly incompatible mechanisms inferred from distinct, indirect biosensor assays. To clarify this apparent contradiction, we developed a split‐YFP‐based bimolecular fluorescence complementation (BiFC) assay to directly visualize receptor‐G o protein complexes at the plasma membrane. Using this system, we found that severe G α o variants fail to disengage from activated Gi/o‐coupled GPCRs, thereby preventing downstream receptor phosphorylation and endocytosis. By contrast, milder dystonia‐linked mutants showed near‐normal receptor internalization and only minor phosphorylation defects. These findings establish dominant GPCR coupling as a molecular hallmark of severe GNAO1 encephalopathies and point to split‐YFP BiFC as a robust platform for probing mutant G protein behavior in genetic disease.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Translational Research Center in Oncohaematology, Department of Cell Physiology and Metabolism, Faculty of Medicine, University of Geneva, Geneva, Switzerland.
- Department of Cell Physiology and Metabolism, Faculty of Medicine, University of Geneva, Geneva, Switzerland.
- Translational Oncology Research Center, Qatar Biomedical Research Institute (QBRI), College of Health and Life Sciences, Hamad Bin Khalifa University (HBKU), Qatar Foundation, Doha, Qatar.
ORCID-Profile: Yonika A Larasati, Camille Rabesahala de Meritens, Miriam Stoeber, Vladimir L Katanaev, Gonzalo P Solis
Zitieren
APA
Larasati, Y. A., de Meritens, C. R., Stoeber, M., Katanaev, V. L., & Solis, G. P. (2026). Pathogenic G α o Mutants Drive Dominant GPCR Coupling in GNAO1 Encephalopathies. The FASEB Journal. https://doi.org/10.1096/fj.202503265r
Vancouver
Larasati YA, de Meritens CR, Stoeber M, Katanaev VL, Solis GP. Pathogenic G α o Mutants Drive Dominant GPCR Coupling in GNAO1 Encephalopathies. The FASEB Journal. 2026. doi:10.1096/fj.202503265r
BibTeX
@article{Larasati2026,
author = {Larasati, Yonika A and de Meritens, Camille Rabesahala and Stoeber, Miriam and Katanaev, Vladimir L and Solis, Gonzalo P},
title = {Pathogenic G α o Mutants Drive Dominant GPCR Coupling in GNAO1 Encephalopathies},
journal = {The FASEB Journal},
year = {2026},
doi = {10.1096/fj.202503265r}
}
EUVIMED